Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Eidos Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16
Revenues0.00.00.0
Cost of goods sold0.00.00.0
Gross profit0.00.00.0
Research and development28.59.31.7
General and administrative9.22.70.7
EBIT-37.8-12.0-2.4
Pre-tax income-40.7-11.9-2.5
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-39.8-11.9-2.5
 
Diluted EPS($1.81)($2.76)($0.69)
Shares outstanding (diluted)22.04.33.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy